
$2 Million for Innovative ALS Clinical Trials
Key highlights
- $2 million awarded for early-stage ALS trials.
- Two innovative therapies being tested: PAS-004 and AP-2.
- Critical funding aims to accelerate drug development.
- Led by top researchers from Mayo Clinic and Molefy Pharma.
Source: PR Newswire
Notable Quotes
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.


